Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 6 analysts

Entrada Therapeutics Inc has a share price target of US$ 18, revenue growth forecast of -84.5%, and profit growth estimate of -330.0% for FY25, based on top 6 analyst calls.